MECHANISM OF ACTION
The Growth Matrix stacks three growth hormone peptides that each do something slightly different. CJC-1295 provides the long-lasting foundation, keeping the pituitary primed to release growth hormone for days from a single dose. Ipamorelin adds precise, clean growth hormone pulses without raising stress hormones. Tesamorelin provides a daily growth hormone signal with a particular focus on visceral fat (the deep belly fat around organs), which is the mechanism the FDA approved it for. Together, they cover three angles at once: a long-term baseline signal (CJC-1295), well-timed pulse quality (Ipamorelin), and targeted fat reduction (Tesamorelin).
RESEARCH APPLICATIONS
- Maximal physiological GH stimulation research
- Body composition - lean mass, visceral fat, and recovery
- Anti-ageing somatopause intervention models
- Cognitive function and GH/IGF-1 axis research
- Post-exercise recovery and anabolic support
RESEARCH HIGHLIGHTS
Triple GH-Axis Stimulation
Each component validated independently; the triple stack provides GHRH baseline (CJC-1295) + GHS-R pulse trigger (Ipamorelin) + daily GHRH reinforcement with visceral specificity (Tesamorelin).
Ref: See individual compound pages
RESEARCH PROTOCOL NOTES
Chemical Identity
Storage & Stability
2–8°C. Reconstituted blend: 2–8°C, 21 days. Follow Tesamorelin storage (most sensitive component).
Regulatory Status
All components WADA S2 prohibited. Research compound. SA research import authorisation required.